Comment on: Efficacy and Safety of the Duodenojejunal Bypass Liner in Patients With Metabolic Syndrome. Not Yet the Time to Abandon the Duodenal-Jejunal Bypass Liner Concept.
Ann Surg
; 274(6): e862-e863, 2021 12 01.
Article
in En
| MEDLINE
| ID: mdl-33443892
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Obesity, Morbid
/
Metabolic Syndrome
/
Bariatric Surgery
Limits:
Humans
Language:
En
Journal:
Ann Surg
Year:
2021
Document type:
Article
Country of publication:
United States